Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18550
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHigginbotham, James N-
dc.contributor.authorZhang, Qin-
dc.contributor.authorJeppesen, Dennis K-
dc.contributor.authorScott, Andrew M-
dc.contributor.authorManning, H Charles-
dc.contributor.authorOchieng, Josiah-
dc.contributor.authorFranklin, Jeffrey L-
dc.contributor.authorCoffey, Robert J-
dc.date2016-
dc.date.accessioned2018-08-30T06:23:37Z-
dc.date.available2018-08-30T06:23:37Z-
dc.date.issued2016-06-24-
dc.identifier.citationJournal of extracellular vesicles 2016; 5: 29254-
dc.identifier.issn2001-3078-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/18550-
dc.description.abstractExosomes are small, 40-130 nm secreted extracellular vesicles that recently have become the subject of intense focus as agents of intercellular communication, disease biomarkers and potential vehicles for drug delivery. It is currently unknown whether a cell produces different populations of exosomes with distinct cargo and separable functions. To address this question, high-resolution methods are needed. Using a commercial flow cytometer and directly labelled fluorescent antibodies, we show the feasibility of using fluorescence-activated vesicle sorting (FAVS) to analyse and sort individual exosomes isolated by sequential ultracentrifugation from the conditioned medium of DiFi cells, a human colorectal cancer cell line. EGFR and the exosomal marker, CD9, were detected on individual DiFi exosomes by FAVS; moreover, both markers were identified by high-resolution stochastic optical reconstruction microscopy on individual, approximately 100 nm vesicles from flow-sorted EGFR/CD9 double-positive exosomes. We present evidence that the activation state of EGFR can be assessed in DiFi-derived exosomes using a monoclonal antibody (mAb) that recognizes "conformationally active" EGFR (mAb 806). Using human antigen-specific antibodies, FAVS was able to detect human EGFR and CD9 on exosomes isolated from the plasma of athymic nude mice bearing DiFi tumour xenografts. Multicolour FAVS was used to simultaneously identify CD9, EGFR and an EGFR ligand, amphiregulin (AREG), on human plasma-derived exosomes from 3 normal individuals. These studies demonstrate the feasibility of FAVS to both analyse and sort individual exosomes based on specific cell-surface markers. We propose that FAVS may be a useful tool to monitor EGFR and AREG in circulating exosomes from individuals with colorectal cancer and possibly other solid tumours.-
dc.language.isoeng-
dc.subjectEGFR-
dc.subjectAmphiregulin-
dc.subjectCetuximab-
dc.subjectColorectal cancer-
dc.subjectExosomes-
dc.subjectExtracellular vesicles-
dc.subjectFlow cytometry-
dc.subjectmAb 806-
dc.subjectxenograft models-
dc.titleIdentification and characterization of EGF receptor in individual exosomes by fluorescence-activated vesicle sorting.-
dc.typeJournal Article-
dc.identifier.journaltitleJournal of extracellular vesicles-
dc.identifier.affiliationDepartment of Veterans Affairs Medical Center, Nashville, TN, USAen
dc.identifier.affiliationDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USAen
dc.identifier.affiliationTumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Molecular Imaging and Therapy, Austin Health, Heidelberg,Victoria, Australiaen
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationCenter for Molecular Probes, Vanderbilt University Institute of Imaging Science, Nashville, TN, USAen
dc.identifier.affiliationDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USAen
dc.identifier.affiliationDepartments of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN, USAen
dc.identifier.affiliationDepartment of Cell and Developmental Biology, Nashville, TN, USAen
dc.identifier.orcid0000-0002-6656-295X-
dc.identifier.pubmedid27345057-
dc.type.austinJournal Article-
local.name.researcherScott, Andrew M
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.